StockData
Evaxion A/S logo

Evaxion A/S (EVAX) stock

EVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 2/30
$2.77+0.03 (+1.09%)

Close on Nov 16, 2026Market cap $23.10MP/E –Yield –

Evaxion A/S enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Evaxion A/S's enterprise value was $9.96M on Nov 11, 2026, against $836.60K a year earlier. Over the last 4 years it ranged from -$2.58M to $30.75M, with a median of $10.09M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$9.96M–
2025Dec 31, 2025-$413.32K-115.1%
2024Dec 31, 2024$2.74M-84.2%
2023Dec 29, 2023$17.32M–

More Evaxion A/S figures

See a number that looks wrong?